The Relationship Between Manic Episodes and Serum Endocannabinoid Levels in Bipolar Disorder
The International Journal of Neuropsychopharmacology · 10.11.2026
DOI: 10.1093/ijnp/pyag050 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Neuropsychopharmacology, online erschienen am 10.11.2026. Verfasst von Sarpkan Özel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Trakya University Faculty of Medicine, Edirne, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Endocannabinoids are involved in biological processes relevant to mood regulation, and altered circulating levels have been reported in bipolar disorder (BD). However, serum endocannabinoid levels have not previously been examined across mania and remission within the same patients and compared with healthy controls. This study evaluated serum palmitoylethanolamide (PEA), oleoylethanolamide (OEA), 2-arachidonoylglycerol (2-AG), anandamide (AEA), and C-reactive protein (CRP) levels in patients with BD during manic episodes and remission and in healthy controls.
Methods
Fifty-one patients diagnosed with BD, manic episode, according to DSM-5-TR criteria, and 49 healthy controls were included. After discharge, 32 patients who attended outpatient follow-up visits were re-evaluated during remission. Serum PEA, OEA, 2-AG, AEA, and CRP levels were measured in all participants. Patients with BD were additionally assessed using the Young Mania Rating Scale, Hamilton Depression Rating Scale, and Positive and Negative Syndrome Scale.
Results
Serum PEA and OEA levels were significantly lower during manic episodes than in healthy controls. During remission, serum PEA and OEA levels did not differ significantly from those of healthy controls. In within-patient comparisons between manic episodes and remission, only serum PEA levels were significantly lower during manic episodes.
Conclusion
This is the first study to assess serum endocannabinoid levels in patients with BD during both manic episodes and remission, together with healthy controls. PEA and OEA levels were significantly lower during mania and returned to values comparable to healthy controls during remission. These findings suggest that endocannabinoid-related mechanisms may have potential as future biomarkers and therapeutic targets in mood regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Trakya University Faculty of Medicine, Edirne, Türkiye.
- Department of Medical Pharmacology, Trakya University Faculty of Medicine, Edirne, Türkiye.
ORCID-Profile: Sarpkan Özel, Yasemin Görgülü, Ruhan Deniz Topuz
Zitieren
APA
Özel, S., Görgülü, Y., & Topuz, R. D. (2026). The Relationship Between Manic Episodes and Serum Endocannabinoid Levels in Bipolar Disorder. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyag050
Vancouver
Özel S, Görgülü Y, Topuz RD. The Relationship Between Manic Episodes and Serum Endocannabinoid Levels in Bipolar Disorder. The International Journal of Neuropsychopharmacology. 2026. doi:10.1093/ijnp/pyag050
BibTeX
@article{zel2026,
author = {Özel, Sarpkan and Görgülü, Yasemin and Topuz, Ruhan Deniz},
title = {The Relationship Between Manic Episodes and Serum Endocannabinoid Levels in Bipolar Disorder},
journal = {The International Journal of Neuropsychopharmacology},
year = {2026},
doi = {10.1093/ijnp/pyag050}
}
EUVIMED